[JF China Region Fund, Inc. INVESTMENT PORTFOLIO] [OF THE SARBANES-OXLEY ACT I, Simon Crinage, certify that: 1. I have reviewed this report on Form N-Q of JF China Region Fund, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under]
[JF China Region Fund, Inc. INVESTMENT PORTFOLIO] [OF THE SARBANES-OXLEY ACT I, Simon Crinage, certify that: 1. I have reviewed this report on Form N-Q of JF China Region Fund, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under]
[JF China Region Fund, INVESTMENT PORTFOLIO DESCRIPTIONS MARKETMMON STOCKS (unless otherwise noted) CHINA (37.0%)mmercial Banks (12.8%) Bank of China H 5,465,000 2,877,039 Bank ofmmunications H 836,000 1,018,295 Chinanstruction Bankrp., H 5,342,000 4,266,680 Industrial &mmercial Bank of China, H 4,912,000 3,701,406] [OF THERBANES-OXLEY ACT I, Simon Crinage, certify that: 1. I have reviewed this report on Form N-Q of JF China Region Fund,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the]
[JF China Region Fund, INVESTMENT PORTFOLIO DESCRIPTIONS MARKETMMON STOCKS (unless otherwise noted) CHINA (37.0%)mmercial Banks (12.8%) Bank of China H 5,465,000 2,877,039 Bank ofmmunications H 836,000 1,018,295 Chinanstruction Bankrp., H 5,342,000 4,266,680 Industrial &mmercial Bank of China, H 4,912,000 3,701,406] [OF THERBANES-OXLEY ACT I, Simon Crinage, certify that: 1. I have reviewed this report on Form N-Q of JF China Region Fund,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the]
[Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities -Sinovac to Own 55% in Joint Venture by Year End 2010- BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian).] [01 - 32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
[eFuture Announces Second Quarter 2009 Unaudited Financial Results and First Quarter 2009 Unaudited Restated Financial Results BEIJING, PRC As noted in previous press releases, the Company reviewed its accounting for certain matters in the First Quarter and has determined that a restatement of unaudited financial information for the First Quarter is appropriate. The Company previously released unaudited financial information for] [FORM 6-K eFuture Information Technology Inc. 8/F TopNew Tower 2 15 Guanghua Road Chaoyang District Beijing 100026, People’s Republic of China 86-10-51650988 x o Form 20-F o x 2 EFUTURE INFORMATION TECHNOLOGY INC.]
[JF China Region Fund, INVESTMENT PORTFOLIO DESCRIPTIONS MARKETMMON STOCKS (unless otherwise noted) CHINA (37.0%)mmercial Banks (12.8%) Bank of China H 5,465,000 2,877,039 Bank ofmmunications H 836,000 1,018,295 Chinanstruction Bankrp., H 5,342,000 4,266,680 Industrial &mmercial Bank of China, H 4,912,000 3,701,406] [OF THERBANES-OXLEY ACT I, Simon Crinage, certify that: 1. I have reviewed this report on Form N-Q of JF China Region Fund,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the]
[eFuture Announces Second Quarter 2009 Unaudited Financial Results and First Quarter 2009 Unaudited Restated Financial Results BEIJING, PRC As noted in previous press releases, the Company reviewed its accounting for certain matters in the First Quarter and has determined that a restatement of unaudited financial information for the First Quarter is appropriate. The Company previously released unaudited financial information for] [FORM 6-K eFuture Information Technology Inc. 8/F TopNew Tower 2 15 Guanghua Road Chaoyang District Beijing 100026, People’s Republic of China 86-10-51650988 x o Form 20-F o x 2 EFUTURE INFORMATION TECHNOLOGY INC.]
[INFORMATION REQUIRED IN REGISTRATION STATEMENT CONCORD MEDICAL SERVICES HOLDINGS LIMITED Jianyu Yang Director, Chief Executive Officer and President Dated: November 27, 2009 8-A12B 1 h03825e8va12b.htm 8-A12B]
[INFORMATION REQUIRED IN REGISTRATION STATEMENT CONCORD MEDICAL SERVICES HOLDINGS LIMITED Jianyu Yang Director, Chief Executive Officer and President Dated: November 27, 2009 8-A12B 1 h03825e8va12b.htm 8-A12B]
